Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 2 | |
Hold | 7 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in EUR
The 11 analysts offering 12 month price targets for SCHOTT Pharma AG & Co KgaA have a median target of 33.00, with a high estimate of 39.00 and a low estimate of 31.00. The median estimate represents a 13.09% increase from the last price of 29.18.
High | 33.7% | 39.00 |
Med | 13.1% | 33.00 |
Low | 6.2% | 31.00 |
Dividends
Div growth (TTM) | -- |
---|
More ▼
Earnings history & estimates in EUR
The next earnings announcement is expected on Dec 12, 2024.
Average growth rate | +22.35% |
More ▼
Revenue history & estimates in EUR
Average growth rate | +3.59% |
More ▼